Global Glycated Hemoglobin Testing Market 2015-2019

グリコヘモグロビン(HbA1c)検査の世界市場

◆タイトル:Global Glycated Hemoglobin Testing Market 2015-2019
◆商品コード:IRTNTR5368
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年2月25日
◆ページ数:92
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、グリコヘモグロビン(HbA1c)検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、グリコヘモグロビン(HbA1c)検査の世界市場規模及び予測、技術別分析、地域別分析、主要国別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Glycated Hemoglobin Testing
Glycated hemoglobin helps measure the concentration of glucose in the blood of an individual. HbA1c, a specific chemical form of glycated hemoglobin, is used to determine a person’s average blood glucose level over a period. It is a standardized test recommended by doctors for the diagnosis of type 2 diabetes or to test the control level of the blood glucose. The testing can be done in a laboratory or at a POC center. Different types of technologies, such as chromatography, immunoassay, capillary electrophoresis, direct enzymatic assay, and micro-optical detection method, are used in HbA1c testing.

TechNavio’s analysts forecast the Global Glycated Hemoglobin Testing market to grow at a CAGR of 10.22 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of Global Glycated Hemoglobin Testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of HbA1c products, including
• Laboratory HbA1c testing products
• POC HbA1c testing products

Based on technology, the market can be characterized into the following segments:
• Chromatography
• Immunoassay
• Others (Capillary Electrophoresis, Direct Enzymatic Assay, and Micro-optical Detection Method)

TechNavio’s report, the Global Glycated Hemoglobin Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Glycated Hemoglobin Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Abbott Laboratories
• Alere
• Danaher
• F. Hoffmann-La Roche

[Other Prominent Vendors]
• Arkray
• Bayer
• Bio-Rad Laboratories
• Ceragem Medisys
• Chek Diagnostics
• Daiichi Biotech
• DiaSys Diagnostic Systems
• Diazyme Laboratories
• EKF Diagnostics
• Erba Mannheim
• Human Diagnostics
• Lite-On Technology
• Menarini
• Mindray Medical
• Randox Laboratories
• Sebia
• Siemens Healthcare
• TaiDoc Technology
• Tosoh Bioscience
• Trinity Biotech

[Market Driver]
• Increased Incidence of Diabetes
• For a full, detailed list, view our report

[Market Challenge]
• Availability of Substitutes
• For a full, detailed list, view our report

[Market Trend]
• Adoption of POC HbA1c Testing
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Overview
06.1 Diabetes
06.2 HbA1c

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Glycated Hemoglobin Testing Market in US
07.3.1 Market Size and Forecast
07.4 Glycated Hemoglobin Testing Market in Japan
07.4.1 Market Size and Forecast
07.5 Glycated Hemoglobin Testing Market in Germany
07.5.1 Market Size and Forecast
07.6 Five Forces Analysis

08.Market Segmentation by Technology

09.Market Segmentation by Method
09.1 Global Laboratory HbA1c Testing Market
09.1.1 Market Size and Forecast
09.2 Global POC HbA1c Testing Market
09.2.1 Market Size and Forecast

10.Geographical Segmentation
10.1 Glycated Hemoglobin Testing Market in Americas
10.1.1 Market Size and Forecast
10.2 Glycated Hemoglobin Testing Market in EMEA Region
10.2.1 Market Size and Forecast
10.3 Glycated Hemoglobin Testing Market in APAC Region
10.3.1 Market Size and Forecast

11.Key Leading Countries
11.1 US
11.2 Japan
11.3 Germany

12.Market Segmentation by Country
12.1 Global Glycated Hemoglobin Testing Market by Country
12.1.1 Market Overview
12.2 Global HbA1c Chromatography Testing Market by Country
12.2.1 Market Overview
12.3 Global HbA1c Immunoassay Testing Market by Country
12.3.1 Market Overview
12.4 Global POC HbA1c Testing Market by Country
12.4.1 Market Overview

13.Buying Criteria

14.Market Growth Drivers

15.Drivers and their Impact

16.Market Challenges

17.Impact of Drivers and Challenges

18.Market Trends

19.Trends and their Impact

20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Vendor Analysis 2014
20.3 Other Prominent Vendors

21.Key Vendor Analysis
21.1 Abbott Laboratories
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue
21.1.4 Business Segmentation by Revenue 2011 and 2012
21.1.5 Geographical Segmentation by Revenue
21.1.6 Business Strategy
21.1.7 Key Information
21.1.8 SWOT Analysis
21.2 Alere
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Danaher
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Segmentation by Geography
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 F. Hoffmann-La Roche
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Geographical Segmentation by Revenue 2013
21.4.5 Business Strategy
21.4.6 Key Information
21.4.7 SWOT Analysis

22.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Executive Summary of Global Glycated Hemoglobin Testing Market 2014-2019
Exhibit 3: Causes of Diabetes
Exhibit 4: Symptoms of Diabetes
Exhibit 5: Formation of HbA1c
Exhibit 6: Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 7: Glycated Hemoglobin Testing Market in US 2014-2019 (US$ million)
Exhibit 8: Glycated Hemoglobin Testing Market in Japan 2014-2019 (US$ million)
Exhibit 9: Glycated Hemoglobin Testing Market in Germany 2014-2019 (US$ million)
Exhibit 10: Segmentation of Global Glycated Hemoglobin Testing Market by Technology
Exhibit 11: Global Glycated Hemoglobin Testing Market by Technology 2014
Exhibit 12: Segmentation of Global Glycated Hemoglobin Testing Market by Method
Exhibit 13: Global Glycated Hemoglobin Testing Market by Method 2014 and 2019
Exhibit 14: Segmentation of Global Glycated Hemoglobin Testing Market (US$ million) and CAGR 2014 and 2019
Exhibit 15: Global Laboratory HbA1c Testing Market 2014-2019 (US$ million)
Exhibit 16: Global POC HbA1c Testing Market 2014-2019 (US$ million)
Exhibit 17: Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 18: Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019
Exhibit 19: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014 and 2019
Exhibit 20: Segmentation of Global Glycated Hemoglobin Testing Market (US$ million) and CAGR 2014 and 2019
Exhibit 21: Glycated Hemoglobin Testing Market in Americas 2014-2019 (US$ million)
Exhibit 22: Glycated Hemoglobin Testing Market in EMEA Region 2014-2019 (US$ million)
Exhibit 23: Glycated Hemoglobin Testing Market in APAC Region 2014-2019 (US$ million)
Exhibit 24: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (US$ million)
Exhibit 25: Geographical Segmentation of Global Glycated Hemoglobin Testing Market 2014-2019 (in percent)
Exhibit 26: Global Glycated Hemoglobin Testing Market by Country 2014
Exhibit 27: Global HbA1c Chromatography Testing Market by Country 2014
Exhibit 28: Global HbA1c Immunoassay Testing Market by Country 2014
Exhibit 29: Global HbA1c POC Testing Market by Country 2014
Exhibit 30: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 31: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 32: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 33: Global Glycated Hemoglobin Testing Market: Business Segmentation by Revenue 2013
Exhibit 34: Global Glycated Hemoglobin Testing Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 35: Global Glycated Hemoglobin Testing Market: Geographical Segmentation by Revenue 2013
Exhibit 36: Danaher: Business Segmentation
Exhibit 37: Danaher: Business Segmentation 2013
Exhibit 38: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 39: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 40: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 41: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 42: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
Exhibit 43: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)



【掲載企業】

Abbott Laboratories, Alere, Danaher, F. Hoffmann-La Roche  , Arkray  , Bayer  , Bio-Rad Laboratories, Ceragem Medisys, Chek Diagnostics, Daiichi Biotech, DiaSys Diagnostic Systems, Diazyme Laboratories , EKF Diagnostics, Erba Mannheim, HumanDiagnostics, Lite-On Technology, Menarini  , Mindray Medical, Randox Laboratories  , Sebia, Siemens Healthcare, TaiDoc Technology, Tosoh Bioscience, Trinity Biotech

【資料のキーワード】

グリコヘモグロビン(HbA1c)検査、糖化ヘモグロビン、糖尿病、血液検査、クロマトグラフィー、イムノクロマト法、キャピラリー電気泳動

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[グリコヘモグロビン(HbA1c)検査の世界市場] (Global Glycated Hemoglobin Testing Market 2015-2019 / IRTNTR5368)販売に関する免責事項
[グリコヘモグロビン(HbA1c)検査の世界市場] (Global Glycated Hemoglobin Testing Market 2015-2019 / IRTNTR5368)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆